Identifying and Characterizing the Plasmodium vivax TRAMP Protein
Author Information
Author(s): Mongui Alvaro, Angel Diana I, Moreno-Perez Darwin A, Villarreal-Gonzalez Silvana, Almonacid Hannia, Vanegas Magnolia, Patarroyo Manuel A
Primary Institution: Fundación Instituto de Inmunología de Colombia (FIDIC)
Hypothesis
This study aims to identify and characterize the PfTRAMP homologue in P. vivax, known as PvTRAMP, and evaluate its potential as a vaccine candidate.
Conclusion
The study found that PvTRAMP is conserved and recognized by the immune system during natural P. vivax infections, suggesting its potential as a vaccine target.
Supporting Evidence
- PvTRAMP is a 340-amino-acid long antigen that is recognized by the immune system during P. vivax infections.
- The protein is initially located at the parasite's apical end and later on the surface.
- Recombinant PvTRAMP was recognized by sera from infected patients, indicating its immunogenic potential.
Takeaway
Researchers found a protein in the malaria parasite that could help the body fight the disease, and they think it might be useful for making a vaccine.
Methodology
The study involved gene identification, protein expression in E. coli, and immunological assays to assess recognition by sera from infected individuals.
Limitations
The study primarily focused on a single strain of P. vivax and may not represent all strains.
Participant Demographics
Participants were individuals from a P. vivax malaria endemic area in Colombia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website